Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Neurobiol Aging. 2020 Oct 14;97:89–96. doi: 10.1016/j.neurobiolaging.2020.09.023

Table 2.

Coefficients and 95% confidence intervals from linear regression models relating the metabolic syndrome to continuous global brain amyloid standardized uptake value ratio (SUVR) and cortical thickness in the AD signature regions (n=350)

Exposure Group n Model 1 Model 2
β β
(95% Confidence Interval) (95% Confidence Interval)
Global Brain Amyloid SUVR
Metabolic Syndrome Score 350 −0.02 (−0.10, 0.06) −0.01 (−0.09, 0.07)
No Metabolic Syndrome Present 182 Reference Reference
Metabolic Syndrome Present 168 −0.01 (−0.22, 0.20) 0.01 (−0.19, 0.21)
AD Signature Region Cortical Thickness
Metabolic Syndrome Score 350 −0.06 (−0.14, 0.02) −0.06 (−0.14, 0.02)
No Metabolic Syndrome Present 182 Reference Reference
Metabolic Syndrome Present 168 −0.07 (−0.28, 0.14) −0.06 (−0.27, 0.15)

Note: Model 1: Unadjusted

Model 2: Adjusted for age, sex, and APOE-ε4

*

p <0.05